Lunetta M, Le Moli R, Grasso G, Sangiorgio L
Centro Antidiabetico, Ospedale Cannizzaro, Catania, Italy.
Diabetes Res Clin Pract. 1998 Mar;39(3):165-72. doi: 10.1016/s0168-8227(98)00005-9.
The reliability and reproducibility of Michigan Neuropathy Screening Instrument (MNSI), a recently proposed simple test for ambulatory screening of peripheral diabetic neuropathy (PDN), was evaluated on 80 diabetic patients. MNSI was carried out by two diabetologists and repeated after a week. It consisted of the sum of scores varying from 0 to 1 for each abnormality revealed in foot appearance, achilles reflexes presence and vibratory threshold (VPT) by tuning fork (maximum score = 8). Then patients had to go to neurologist for PDN diagnosis by a quantitative neurological examination and electrophysiological evaluation, the so named Michigan Diabetic Neuropathy Score (MDNS) and the results compared with MNSI score according to one of the two observers. The inter-observer reproducibility of MNSI was 88.75% the within observer reproducibility was 95 and 94%, respectively, for each observer with good correlation between the two measurements (P < 0.001). The MNSI score of 2.5 as a cut-off appeared to be reliable for ambulatory screening of suspected PDN (false positive and false negative = 2.5%; specificity and sensitivity = 75% and 78.6%, respectively). In conclusion MNSI by using 2.5 score as cut-off may be considered a rapid, simple, reproducible and reliable test for rapid ambulatory screening of PDN from the diabetologists.
密歇根神经病变筛查工具(MNSI)是最近提出的一种用于门诊筛查糖尿病周围神经病变(PDN)的简单测试方法。我们对80例糖尿病患者评估了该方法的可靠性和可重复性。MNSI由两名糖尿病专家进行操作,并在一周后重复测试。它由足部外观、跟腱反射和音叉振动觉阈值(VPT)中发现的每项异常的得分总和组成,每项异常得分从0到1分(最高分 = 8分)。然后患者必须前往神经科医生处,通过定量神经学检查和电生理评估进行PDN诊断,即所谓的密歇根糖尿病神经病变评分(MDNS),并根据两名观察者之一将结果与MNSI评分进行比较。MNSI的观察者间可重复性为88.75%,观察者内可重复性分别为95%和94%,两次测量之间具有良好的相关性(P < 0.001)。以2.5分为临界值的MNSI评分似乎对疑似PDN的门诊筛查是可靠的(假阳性和假阴性率 = 2.5%;特异性和敏感性分别为75%和78.6%)。总之,对于糖尿病专家而言,以2.5分为临界值的MNSI可被视为一种快速、简单、可重复且可靠的PDN门诊快速筛查测试方法。